MiniMed Flex pump
MiniMed
MiniMed's FDA-cleared, screenless, smartphone-controlled tubed pump: about half the size of the 780G, with app bolusing, a 300-unit reservoir, rechargeable battery lasting at least seven days, waterproofing and Simplera Sync compatibility. US commercial launch began on 17 June 2026.
The scorecard
Launched with the Simplera Sync sensor and MiniMed infusion sets; integration with the Abbott-built Instinct sensor is stated for later in summer 2026. Still a closed MiniMed ecosystem rather than an open pump.[4]
FDA-cleared and built on MiniMed's mature pump/SmartGuard lineage, but the Flex hardware itself lacks long real-world track record.[2]
Small and screenless, about half the 780G form factor, but still a tubed pump rather than a patch pump.[2]
Designed around MiniMed app control, including meal and correction boluses from a compatible device.[1]
300-unit reservoir and a rechargeable battery lasting at least seven days are strong for a compact pump; it also works with MiniMed's Extended infusion set, worn up to seven days.[4]
US commercial launch began on 17 June 2026, following March 2026 FDA clearance (type 1 diabetes from age 7, and adults 18+ with insulin-requiring type 2). Ex-US availability is still ahead and payer coverage is still being built out.[4]
The full picture
MiniMed Flex is the hardware shift in MiniMed's next generation: a screenless tubed pump controlled through the MiniMed app. It preserves the 300-unit capacity and MiniMed infusion-set ecosystem while shrinking the pump and moving bolusing to the phone. Its ranking is deliberately split from the AID-system page: this pump score is about hardware access, form factor and interoperability; the AID page covers SmartGuard automation and the GATEWAY no-meal-bolus signal.
It is now actually shipping
Flex has moved from "cleared" to "on sale". MiniMed announced the start of its first US commercial launch on 17 June 2026, following FDA clearance in March 2026.1 It is indicated for type 1 diabetes from age 7, and for adults 18 and over with insulin-requiring type 2 diabetes. The pump launches with the Simplera Sync sensor, has no screen (control is entirely through the MiniMed app on iOS or Android from day one), holds 300 units, and works with MiniMed's infusion sets — including the Extended set, worn for up to seven days.1 That is why the access score moves up: this is a product you can be prescribed today rather than a clearance you are waiting on. It is still a US-only launch, and payer coverage is only starting to fall into place, which is what keeps the score in the middle of the range rather than near the top.
MiniMed says integration with the Abbott-built Instinct sensor is planned for later in summer 2026.1 Two further items are worth knowing about but should be treated with more caution: reporting from the ADA 2026 conference describes a European launch targeted for early 2027 and a Vivera algorithm software update for Flex (adding optional automatic meal bolusing) in 2027.2 Those are conference round-up claims, not MiniMed announcements, so treat the dates as indicative rather than committed.
References
-
Drug Delivery Business News. MiniMed begins miniature Flex pump rollout in US. Drug Delivery Business News (17 June 2026). https://www.drugdeliverybusiness.com/minimed-begins-flex-pump-rollout-us/ ↩ ↩2 ↩3
-
Diabetotech. Closed-loop updates from ADA 2026. Diabetotech (2026). https://www.diabetotech.com/blog/closed-loop-updates-from-ada-2026 — conference reporting, not a manufacturer statement. ↩
What's next for this
- →Abbott-built Instinct sensor integration with Flex · later in summer 2026
Sources
- [1]MiniMed Flex system product FAQ · manufacturer
- [2]MiniMed announces FDA clearance of MiniMed Flex, its smallest insulin pump and first smartphone-controlled design · manufacturer · 2026-03-18
- [3]GATEWAY safety evaluation of MiniMed NMX8-AID / Flex (NCT07228117) · registry
- [4]MiniMed begins miniature Flex pump rollout in US · news · 2026-06-17
- [5]Closed-loop updates from ADA 2026 (conference reporting) · conference — Conference round-up, not a MiniMed statement — the European launch and Vivera software-update timelines below rest on this reporting alone.